- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 73.78M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 75.6M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 75.2M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $16M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Capex | Q1 2026 · Mar 31, 2026 | $27M |
| Capex | Q1 2026 · Mar 31, 2025 | $29M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$9M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $123M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $2.7B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $2.67B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $80M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $86M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $433M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $456M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $352M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $396M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $403M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.85B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.9B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.25B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $5.27B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.82B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.82B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $5.64B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $5.67B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.29 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $0.19 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.30 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $0.19 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $130M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $122M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $20M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $17M |
| Net Income | Q1 2026 · Mar 31, 2026 | $22M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $14M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $84M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $93M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.04B |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $979M |